Skip to main content
. 2021 Sep 6;12(20):2773–2779. doi: 10.1111/1759-7714.14123

TABLE 2.

Pathologic characteristics and molecular test results in both patients

No. Sample types TTF1 (IHC) Naspin A (IHC) EGFR/KRAS mutations ALK (IHC) ALK (RT‐PCR) ALK (FISH) ALK (NGS) Tumor percentage
P1 LP + + WT/WT + − (12%) EML4‐ALK 80
P2 LP + + WT/WT + + (20%) PRKAR1A‐ALK 40

Abbreviations: LB, lymph nodes biospy; LP, lung puncture; +, positive; −, negative.